Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 13 | $10,872,250 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
03 Apr 2023 19:24 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 30 Mar 2023 | Sale | 131,029 | 17.0025 | 2,227,821 | D |
03 Apr 2023 19:24 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 03 Apr 2023 | Sale | 30,911 | 18 | 556,398 | D |
13 Apr 2023 17:13 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 11 Apr 2023 | Sale | 56,295 | 18.0037 | 1,013,518 | D |
13 Apr 2023 17:13 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 12 Apr 2023 | Sale | 41,544 | 18 | 747,792 | D |
18 Apr 2023 19:07 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 17 Apr 2023 | Sale | 7,500 | 20 | 150,000 | D |
04 Jan 2024 21:35 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 04 Jan 2024 | Sale | 15,000 | 17.9 | 268,500 | D |
03 May 2024 20:51 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 03 May 2024 | Sale | 847 | 76.0743 | 64,435 | D |
03 May 2024 20:51 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 03 May 2024 | Sale | 17,238 | 75.4868 | 1,301,241 | D |
03 May 2024 20:51 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 03 May 2024 | Sale | 45,570 | 74.4447 | 3,392,445 | D |
03 May 2024 20:51 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 03 May 2024 | Sale | 3,101 | 73.4881 | 227,887 | D |
31 Jul 2024 16:05 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 30 Jul 2024 | Sale | 2,974 | 57.71 | 171,630 | D |
31 Jul 2024 16:05 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 30 Jul 2024 | Sale | 500 | 58.71 | 29,355 | D |
31 Jul 2024 16:05 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 30 Jul 2024 | Sale | 12,662 | 56.96 | 721,228 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)